NCT06749535Active, not recruiting
The Detection of Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 27 Dec 2024
Brief summary (registry, in English)
"Background: Chronic obstructive pulmonary disease (COPD) is an ongoing lung condition caused by damage to the lungs. The damage results in swelling and irritation, also called inflammation, inside the airways that limit airflow into and out of the lungs. Diabetes can worsen the progression and prognosis of COPD.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 250 (actual)
- First submitted
- 19 Dec 2024
- Start date
- 28 Feb 2024
- Primary completion date
- 1 Aug 2024
- Lead sponsor
- Superior University
- Diseases
- COPD
- NCT number
- NCT06749535
What you commit to
- Study type: Observational
- Participants enrolled: 250
- From 28 Feb 2024 to the primary completion date, 1 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients having Acute Respiratory Distress Syndrome (ARDS)."
Other
- Patients who smoke prolong.
- Patient having other diseased (asthma, lung carcinoma).
Who the study is looking for
- Age: 30-65 years Gender: Both
- Male and female
- At least 5-10 year history of Diabetes Mellitus
- Chronic Obstructive Pulmonary Disease
Age in the registry: 30 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gulab devi hospital, Ferozepur Rd, Nishtar Town Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.